Mar 08, 2013– San Francisco, USA (Techreleased) – To help clinicians more accurately and efficiently diagnose cardiovascular disease, Toshiba America Medical Systems, Inc. introduces the AplioTM 500 and Aplio 300 CV ultrasound systems. Compact and easy-to-use, Aplio 500 CV and Aplio 300 CV deliver exceptional image quality and advanced technologies to improve patient diagnoses and treatment.
Both the Aplio 500 and 300 CV are the systems of choice for all premium 2D cardiac exams and feature Toshiba’s 2D Wall Motion Tracking technology, which provides stunning visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility. With on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), the Aplio CV systems are designed to get the most comprehensive information anytime and anywhere in the hospital, right at the patient’s bedside.
Additional cardiac-specific technologies include Tissue Enhancement, Advanced Dynamic Flow™, Lateral Gain Controls, Tissue Doppler, Stress Echo, Flex-M Mode and Auto IMT. Both systems are easy to use, with superior ergonomics and a smaller footprint, making them easier to maneuver for greater patient access and improved workflow.
“Aplio 500 and 300 CV provide picture-perfect images with unprecedented resolution, and deliver clinical data faster and more reliably,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Combined with 2D Wall Motion Tracking, physicians can conduct the best bedside cardiac exams and have access to the most comprehensive quantification measurements (strain, strain rates or ejection fraction) on-board the systems and in just three simple clicks.”
Toshiba will showcase Aplio 500 CV and Aplio 300 CV at this year’s American College of Cardiology (ACC) annual meeting in San Francisco, March 9 – 11, 2013 (Booth #5733, North Hall).